ReviewExperimental hematology & oncology2022

Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia.

Xingcheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.